يعرض 1 - 10 نتائج من 666 نتيجة بحث عن '"Lung Embolism"', وقت الاستعلام: 1.27s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3
    دورية أكاديمية

    المصدر: Department of Radiology Faculty Papers

    وصف الملف: application/pdf

  4. 4
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المصدر: JACC: Cardiovascular Interventions

    وصف الملف: application/pdf

    العلاقة: Marukyan, N, Simakova, M, Moiseeva, O & Kashtanov, M 2022, 'Transbronchial Guidance for Balloon Pulmonary Angioplasty in CTEPH: The Safe Guidewire Passage Through the Occlusion', JACC: Cardiovascular Interventions, Том. 15, № 2, стр. e25-e26. https://doi.org/10.1016/j.jcin.2021.11.006Test; Marukyan, N., Simakova, M., Moiseeva, O., & Kashtanov, M. (2022). Transbronchial Guidance for Balloon Pulmonary Angioplasty in CTEPH: The Safe Guidewire Passage Through the Occlusion. JACC: Cardiovascular Interventions, 15(2), e25-e26. https://doi.org/10.1016/j.jcin.2021.11.006Test; Final; All Open Access; Bronze Open Access; https://doi.org/10.1016/j.jcin.2021.11.006Test; http://elar.urfu.ru/handle/10995/132463Test; 85122441246; 745929500005

  7. 7
    دورية أكاديمية
  8. 8
  9. 9
    دورية أكاديمية
  10. 10

    المصدر: European Heart Journal. 43(38):3618-3731

    مصطلحات موضوعية: Balloon pulmonary angioplasty, Chronic thrombo-embolic pulmonary hypertension, Congenital heart disease, Connective tissue disease, Endothelin receptor antagonists, Guidelines, Left heart disease, Lung disease, Lung transplantation, Phosphodiesterase type 5 inhibitors, Prostacyclin analogues, Prostacyclin receptor agonists, Pulmonary arterial hypertension, Pulmonary endarterectomy, Pulmonary hypertension, Soluble guanylate cyclase stimulators, Endothelin Receptor Antagonists, Humans, Hypertension, Pulmonary, ambrisentan, amlodipine, antiretrovirus agent, beraprost, beta adrenergic receptor blocking agent, bosentan, bosutinib, cyclophosphamide, dasatinib, diltiazem, dipeptidyl carboxypeptidase inhibitor, diuretic agent, endothelin receptor antagonist, enkephalinase inhibitor, felodipine, guanylate cyclase activator, iloprost, interferon, ivabradine, macitentan, methamphetamine, mitomycin, nifedipine, phosphodiesterase V inhibitor, Pneumococcus vaccine, ponatinib, prostacyclin, prostacyclin derivative, riociguat, SARS-CoV-2 vaccine, selexipag, sildenafil, sodium glucose cotransporter 2 inhibitor, tadalafil, treprostinil, abdominal radiography, altitude, angioplasty, anticoagulant therapy, aortic stenosis, aortopulmonary shunt, arterial gas, assisted circulation, biochemical analysis, birth control, blood analysis, BMPR2 gene, cardiopulmonary exercise test, cardiovascular magnetic resonance, chronic kidney failure, chronic obstructive lung disease, chronic thromboembolic pulmonary hypertension, clinical decision making, comorbidity, congenital heart disease, connective tissue disease, contraceptive behavior, coronavirus disease 2019, denervation, digital subtraction angiography, disease association, disease classification, disease control, disease course, disease severity, drug approval, drug design, drug potentiation, drug safety, dynamic contrast enhanced computed tomography, early diagnosis, echocardiography, echography, electrocardiogram, Europe, evidence based practice, exercise, fluid challenge test, follow up, gene, genetic counseling, genetic screening, GRADE approach, health care facility, health care management, health care personnel, heart arrhythmia, heart catheterization, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, heart left ventricle hypertrophy, heart lung transplantation, heart right ventricle failure, hematologic disease, hemoptysis, human, Human immunodeficiency virus infection, hypoxia, immunology, intensive care unit, interstitial lung disease, iron deficiency anemia, liver transplantation, lung artery pressure, lung embolism, lung emphysema, lung function test, lung hemodynamics, lung transplantation, mediastinitis, metabolic disorder, microangiopathy, mitral valve disease, mortality risk, noninvasive ventilation, oxygen therapy, pathophysiology, patient compliance, patient empowerment, patient-reported outcome, phase 3 clinical trial (topic), physical activity, pneumococcal infection, portal hypertension, practice guideline, pregnancy, prognosis, psychosocial care, pulmonary artery denervation, pulmonary artery occlusion, pulmonary endarterectomy, pulmonary hypertension, pulmonary tumour thrombotic microangiopathy, rehabilitation care, Review, risk assessment, risk factor, schistosomiasis, surgical technique, systemic disease, systemic sclerosis, telemonitoring, terminal care, thorax radiography, thrombotic microangiopathy, travel, tricuspid valve regurgitation, vaccination, vasoreactivity test, ventilation-perfusion scan, Medicin och hälsovetenskap, Klinisk medicin, Kardiologi, Medical and Health Sciences, Clinical Medicine, Cardiac and Cardiovascular Systems